8-K: Assure Holdings Corp. to Restate Prior Financials Due to Accounting Errors

Sentiment:

8-K Filing


Assure Holdings Corp. announced that its previously released unaudited financial statements for the first three quarters of 2023 should no longer be relied upon due to material accounting errors.

Worse than expectedThe company's financial results for the first three quarters of 2023 were materially misstated and must be restated, indicating worse than expected financial reporting.

Summary

  • Assure Holdings Corp.'s Board of Directors has determined that the company's unaudited financial statements for the quarterly periods ending March 31, 2023, June 30, 2023, and September 30, 2023, should not be relied upon.
  • This decision was made following the identification of material errors during the preparation of the company's 2023 year-end financial statements.
  • The errors include a miscalculation of deferred tax liability related to convertible notes, the omission of stock-based compensation benefits, and an overstatement of accounts receivable and revenue due to a dispute settlement with a commercial insurance payor.
  • The company will restate these financial statements in its upcoming Annual Report on Form 10-K for the year ended December 31, 2023.
  • The errors do not affect the company's cash position at the end of the Non-Reliance Periods.
  • The company has also identified a material weakness in its internal control over financial reporting, which contributed to these errors.

Sentiment

Score: 3

Explanation: The announcement of a restatement due to material accounting errors and a material weakness in internal controls is a significant negative, indicating a lack of financial reporting reliability. The sentiment is further impacted by the ongoing merger process.

Positives

  • The company has identified and is correcting the accounting errors.
  • The errors do not impact the company's cash position.
  • The company is working with its independent auditor to address the issues.

Negatives

  • The company's previously released financial statements for the first three quarters of 2023 are unreliable.
  • There was a material weakness in the company's internal control over financial reporting.
  • The company overstated revenue and accounts receivable by $381 thousand due to a dispute settlement.
  • The company failed to record $144 thousand in stock-based compensation benefits.

Risks

  • The restatement of financial statements could negatively impact investor confidence.
  • The material weakness in internal controls could lead to future accounting errors.
  • The company may face increased scrutiny from regulators and investors.
  • The proposed merger with Danam could be affected by the restatement.

Future Outlook

The company will disclose the restated financial statements in its upcoming Annual Report on Form 10-K for the year ended December 31, 2023. The company expects to continue to report a material weakness in internal controls.

Management Comments

  • The Board concluded that it is appropriate to correct the above errors in accounting in the Company's financial statements for the Non-Reliance Periods.
  • Management has assessed the effect of these restatements on the Company's internal control over financial reporting and its disclosure controls and procedures.
  • The Company expects to continue to report at least this same material weakness as a result of its analysis of the cause of these restatements.

Industry Context

Restatements due to accounting errors are not uncommon, but they can raise concerns about a company's financial reporting practices. This announcement comes as Assure is in the process of a proposed merger with Danam, which could add complexity to the situation.

Comparison to Industry Standards

  • Restatements of financial statements are generally viewed negatively by investors and can lead to a decline in stock price.
  • Companies like Enron and WorldCom have had major restatements that led to significant consequences.
  • The material weakness in internal controls is a concern, as it indicates a lack of proper oversight and processes.
  • Companies in the healthcare sector, such as medical device and service providers, are often subject to complex accounting rules, making them more susceptible to errors.

Stakeholder Impact

  • Shareholders will be impacted by the restatement and potential loss of confidence.
  • Employees may be concerned about the company's financial stability.
  • Customers and suppliers may have concerns about the company's reliability.
  • Creditors may reassess their risk exposure to the company.

Next Steps

  • The company will file restated financial statements in its upcoming Annual Report on Form 10-K for the year ended December 31, 2023.
  • The company will continue to assess and address the material weakness in its internal control over financial reporting.
  • The company will proceed with the proposed merger with Danam, subject to regulatory and shareholder approvals.

Key Dates

DateDescription
2023-03-31End of the first quarter of 2023, one of the periods for which financial statements will be restated.
2023-05-15Date the original 10-Q for the quarter ended March 31, 2023 was filed.
2023-06-30End of the second quarter of 2023, one of the periods for which financial statements will be restated.
2023-08-14Date the original 10-Q for the quarter ended June 30, 2023 was filed.
2023-09-30End of the third quarter of 2023, one of the periods for which financial statements will be restated.
2023-12-05Date of Assure's Definitive Proxy Statement on Schedule 14A relating to the 2023 Annual Meeting of Stockholders.
2023-12-22Date the original 10-Q for the quarter ended September 30, 2023 was filed.
2024-04-24Date of the 8-K filing announcing the restatement of financial statements.
2024-04-26Date the 8-K was signed.

Keywords

financial restatement, accounting errors, internal control weakness, material weakness, deferred tax liability, stock-based compensation, revenue overstatement, accounts receivable, Form 8-K, Assure Holdings Corp

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.